Veradigm Inc. (MDRX)
OTCMKTS
· Delayed Price · Currency is USD
5.40
+0.05 (0.93%)
Feb 18, 2025, 4:00 PM EST
Veradigm Revenue
Veradigm had revenue of $151.92M in the quarter ending September 30, 2022, with 5.01% growth. This brings the company's revenue in the last twelve months to $1.53B, up 89.72% year-over-year. In the year 2021, Veradigm had annual revenue of $1.50B with 0.02% growth.
Revenue (ttm)
1.53B
Revenue Growth
+89.72%
P/S Ratio
0.41
Revenue / Employee
191.13K
Employees
8,000
Market Cap
915.69M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2021 | 1.50B | 337.00K | 0.02% |
Dec 31, 2020 | 1.50B | -129.91M | -7.96% |
Dec 31, 2019 | 1.63B | 14.77M | 0.91% |
Dec 31, 2018 | 1.62B | 120.13M | 8.02% |
Dec 31, 2017 | 1.50B | 111.64M | 8.05% |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Dec 31, 2013 | Pro | Pro | Pro |
Dec 31, 2012 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.79B |
SS Innovations International | 16.04M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 188.29M |
Northwest Biotherapeutics | 1.60M |
BioStem Technologies | 210.49M |
SANUWAVE Health | 29.30M |
Silence Therapeutics | 21.77M |
Veradigm News
- 19 hours ago - Veradigm Introduces Cardiometabolic Clinical Registry Datasets to Enhance the Next Generation of Real-World Research - Business Wire
- 7 days ago - Veradigm Inc (MDRX) Stock Dips Amid Market Volatility - GuruFocus
- 15 days ago - Black Book Ranks Veradigm EHR the #1 Ambulatory EHR for Family Practice and Primary Care Practices - Business Wire
- 19 days ago - Veradigm ends strategic review after no firm bids - Seeking Alpha
- 19 days ago - Veradigm Concludes Exploration of Strategic Alternatives and Announces Operational Review - Business Wire
- 19 days ago - Veradigm Announces the Resignation of Board Director Beth Altman Due to Health Reasons - Business Wire
- 20 days ago - Veradigm Inc (MDRX) Stock Drops 5% Amid Market Volatility - GuruFocus
- 5 weeks ago - Veradigm Adds Social Determinants of Health and Mortality Data to EHR Database to Allow Deeper Insights into the Patient Journey - Business Wire